|
AU1752792A
(en)
|
1991-03-08 |
1992-10-06 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors
|
|
DE19833786A1
(de)
|
1998-07-18 |
2000-01-20 |
Schering Ag |
Benzocycloheptene, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
|
|
EP1229036B1
(en)
|
2001-01-24 |
2005-01-12 |
CHIESI FARMACEUTICI S.p.A. |
2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
|
|
PL374215A1
(en)
|
2001-08-11 |
2005-10-03 |
Bristol-Myers Squibb Pharma Company |
Selective estrogen receptor modulators
|
|
DK1501819T3
(da)
|
2002-04-24 |
2011-01-10 |
Merck Sharp & Dohme |
Østrogenreceptormodulatorer
|
|
CA2512000C
(en)
|
2002-12-26 |
2011-08-09 |
Eisai Co., Ltd. |
Selective estrogen receptor modulator
|
|
WO2006012135A1
(en)
|
2004-06-24 |
2006-02-02 |
Janssen Pharmaceutica, N. V. |
Quaternary salt ccr2 antagonists
|
|
ES2551086T3
(es)
|
2005-06-14 |
2015-11-16 |
Baylor University |
Análogos de combretastatina con actividad de unión a tubulina
|
|
US8127618B1
(en)
|
2007-05-18 |
2012-03-06 |
Pacesetter, Inc. |
Implantable micro-electromechanical system sensor
|
|
EP2048126A1
(de)
|
2007-10-11 |
2009-04-15 |
Bayer Schering Pharma AG |
Benzocycloheptanderivate als selektiv wirksame Estrogene
|
|
WO2009101634A2
(en)
|
2008-02-13 |
2009-08-20 |
Lupin Limited |
A novel process for the preparation of eszopiclone
|
|
DE102010030538A1
(de)
|
2010-06-25 |
2011-12-29 |
Bayer Schering Pharma Aktiengesellschaft |
6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
|
|
GB2483736B
(en)
|
2010-09-16 |
2012-08-29 |
Aragon Pharmaceuticals Inc |
Estrogen receptor modulators and uses thereof
|
|
WO2012068284A2
(en)
|
2010-11-16 |
2012-05-24 |
Baylor University |
Efficient method for preparing functionalized benzosuberenes
|
|
CA2819299A1
(en)
|
2010-12-24 |
2012-06-28 |
Merck Sharp & Dohme B.V. |
N-substituted azetidine derivatives
|
|
DE102011087987A1
(de)
|
2011-12-08 |
2013-06-13 |
Bayer Intellectual Property Gmbh |
6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
|
|
WO2013097773A1
(en)
|
2011-12-30 |
2013-07-04 |
Centaurus Biopharma Co., Ltd. |
Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators
|
|
CN102584687A
(zh)
|
2011-12-30 |
2012-07-18 |
北京赛林泰医药技术有限公司 |
作为选择性雌激素受体调节剂的乙烯衍生物
|
|
CN105828822B
(zh)
|
2013-08-14 |
2019-10-18 |
诺华股份有限公司 |
用于治疗癌症的组合疗法
|
|
WO2015028409A1
(de)
|
2013-08-27 |
2015-03-05 |
Bayer Pharma Aktiengesellschaft |
6,7-dihydro-5h-benzo[7]annulen-derivate, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln
|
|
EP3089747A1
(en)
|
2013-12-06 |
2016-11-09 |
F. Hoffmann-La Roche AG |
Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer
|
|
KR102598782B1
(ko)
|
2014-10-03 |
2023-11-07 |
노파르티스 아게 |
알펠리십을 포함하는 제약 조성물
|
|
WO2016097071A1
(en)
|
2014-12-18 |
2016-06-23 |
F. Hoffmann-La Roche Ag |
Estrogen receptor modulators and uses thereof
|
|
TWI874834B
(zh)
|
2014-12-18 |
2025-03-01 |
瑞士商赫孚孟拉羅股份公司 |
四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途
|
|
KR20250152679A
(ko)
|
2015-04-29 |
2025-10-23 |
래디어스 파마슈티컬스, 인코포레이티드 |
암을 치료하는 방법
|
|
US10144728B2
(en)
*
|
2015-10-06 |
2018-12-04 |
Dow Agrosciences Llc |
Alkylation of picolinamides with substituted chloroacylals utilizing a crown ether catalyst
|
|
CN106924210A
(zh)
|
2015-12-29 |
2017-07-07 |
北京新领先医药科技发展有限公司 |
一种含有帕布昔利布的胶囊剂及其制备方法
|
|
EA034994B1
(ru)
*
|
2016-02-15 |
2020-04-15 |
Санофи |
6,7-дигидро-5h-бензо[7]аннуленовые производные в качестве модуляторов эстрогеновых рецепторов
|
|
ES3039455T3
(en)
|
2016-11-17 |
2025-10-21 |
Sanofi Sa |
Novel substituted n-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof
|
|
EP3434272A1
(en)
|
2017-07-25 |
2019-01-30 |
Sanofi |
Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid
|
|
CN111386113A
(zh)
|
2017-12-01 |
2020-07-07 |
诺华股份有限公司 |
包含lsz102和阿培利司的药物组合
|
|
CN109896991B
(zh)
|
2017-12-08 |
2020-11-20 |
苏州远智医药科技有限公司 |
一种δ阿片受体拮抗剂及其用途和药物组合物
|
|
TWI702219B
(zh)
*
|
2018-07-12 |
2020-08-21 |
美商美國禮來大藥廠 |
選擇性雌激素受體降解劑
|
|
BR112021003440A2
(pt)
|
2018-09-07 |
2021-05-18 |
Sanofi |
sais de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil) pirrolidin-3-il]oxifenil]-8,9-di-hidro-7h-benzo[7]anuleno-2-carboxilato de metila e seu processo de preparação
|
|
AU2019379179A1
(en)
|
2018-11-16 |
2021-06-10 |
Arqule, Inc. |
Pharmaceutical combination for treatment of cancer
|
|
MX2021005876A
(es)
|
2018-11-30 |
2021-07-16 |
Radius Pharmaceuticals Inc |
Elacestrant en combinacion con abemaciclib en mujeres con cancer de mama.
|
|
CA3146346A1
(en)
|
2019-05-09 |
2020-11-12 |
Sanofi |
6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid for use in metastatic or advanced breast cancer patients
|
|
EP4037768B1
(en)
|
2019-10-01 |
2023-10-11 |
Sanofi |
Novel substituted 6,7-dihydro-5h-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof
|
|
AU2020399168A1
(en)
|
2019-12-09 |
2022-07-28 |
Sanofi |
Crystalline form of a 7H-benzo[7]annulene-2-carboxylic acid derivative
|
|
EP4069225A4
(en)
*
|
2019-12-20 |
2023-12-27 |
Recurium IP Holdings, LLC |
COMBINATIONS
|
|
CA3169679A1
(en)
*
|
2020-03-06 |
2021-09-10 |
Olema Pharmaceuticals, Inc. |
Methods of treating estrogen receptor-associated diseases
|
|
WO2022084280A1
(en)
|
2020-10-19 |
2022-04-28 |
Sanofi |
Substituted 6,7-dihydro-5h-benzo[7]annulene compounds and their derivatives, processes for their preparation and therapeutic uses thereof
|
|
TW202233572A
(zh)
|
2020-10-19 |
2022-09-01 |
法商賽諾菲公司 |
新穎之經取代的6,7-二氫-5h-苯並[7]輪烯衍生物，其製備方法及其治療用途
|
|
WO2022106711A1
(en)
|
2020-11-23 |
2022-05-27 |
Sanofi |
Combination comprising abemaciclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid
|
|
TW202304425A
(zh)
|
2021-04-12 |
2023-02-01 |
法商賽諾菲公司 |
包含瑞博西尼和安森司群（ａｍｃｅｎｅｓｔｒａｎｔ）的組合
|
|
TW202304424A
(zh)
|
2021-04-12 |
2023-02-01 |
法商賽諾菲公司 |
包含依維莫司和安森司群的組合
|